Published in Clin Cases Miner Bone Metab on January 01, 2010
Nanotechnology for treating osteoporotic vertebral fractures. Int J Nanomedicine (2015) 0.77
The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care (1993) 27.05
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser (1994) 17.37
Epidemiology and outcomes of osteoporotic fractures. Lancet (2002) 13.09
A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med (2009) 11.20
Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet (2009) 6.66
[Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty]. Neurochirurgie (1987) 5.88
The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76
New technologies in spine: kyphoplasty and vertebroplasty for the treatment of painful osteoporotic compression fractures. Spine (Phila Pa 1976) (2001) 4.79
Initial outcome and efficacy of "kyphoplasty" in the treatment of painful osteoporotic vertebral compression fractures. Spine (Phila Pa 1976) (2001) 3.99
Vertebroplasty and kyphoplasty: a systematic review of 69 clinical studies. Spine (Phila Pa 1976) (2006) 3.92
Percutaneous vertebroplasty for pain relief and spinal stabilization. Spine (Phila Pa 1976) (2000) 3.75
Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects. AJNR Am J Neuroradiol (1998) 3.69
Mortality after osteoporotic fractures. Osteoporos Int (2003) 3.68
Occurrence of new vertebral body fracture after percutaneous vertebroplasty in patients with osteoporosis. Radiology (2003) 3.30
Percutaneous vertebroplasty with polymethylmethacrylate. Technique, indications, and results. Radiol Clin North Am (1998) 3.21
Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1999) 3.08
A review of complications associated with vertebroplasty and kyphoplasty as reported to the Food and Drug Administration medical device related web site. J Vasc Interv Radiol (2004) 2.94
Vertebral compression fractures: pain reduction and improvement in functional mobility after percutaneous polymethylmethacrylate vertebroplasty retrospective report of 245 cases. Radiology (2003) 2.76
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Percutaneous vertebroplasty compared with optimal pain medication treatment: short-term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. AJNR Am J Neuroradiol (2007) 2.66
Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg (2003) 2.49
Percutaneous vertebroplasty: functional improvement in patients with osteoporotic compression fractures. Spine (Phila Pa 1976) (2006) 2.43
Clinical outcomes after acute osteoporotic vertebral fractures: a 2-year non-randomised trial comparing percutaneous vertebroplasty with conservative therapy. Med J Aust (2006) 2.40
Percutaneous vertebroplasty: state of the art. Radiographics (1998) 2.29
Vertebroplasty in patients with severe vertebral compression fractures: a technical report. AJNR Am J Neuroradiol (2000) 2.27
Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement. Radiology (1996) 2.23
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20
The biomechanics of vertebroplasty. The effect of cement volume on mechanical behavior. Spine (Phila Pa 1976) (2001) 2.13
Kyphoplasty for treatment of osteoporotic vertebral fractures: a prospective non-randomized study. Eur Spine J (2004) 2.10
Biomechanical evaluation of a new bone cement for use in vertebroplasty. Spine (Phila Pa 1976) (2000) 2.08
Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: an open prospective study. J Rheumatol (1999) 2.07
Percutaneous vertebroplasty: a developing standard of care for vertebral compression fractures. AJNR Am J Neuroradiol (2001) 2.06
New fractures after vertebroplasty: adjacent fractures occur significantly sooner. AJNR Am J Neuroradiol (2006) 2.05
Kyphoplasty treatment of vertebral fractures: 2-year outcomes show sustained benefits. Spine (Phila Pa 1976) (2006) 2.00
Complications of percutaneous vertebroplasty and their prevention. Skeletal Radiol (2004) 1.96
Percutaneous transpedicular vertebroplasty with PMMA: operative technique and early results. A prospective study for the treatment of osteoporotic compression fractures. Eur Spine J (2000) 1.96
Comparison of vertebroplasty and balloon kyphoplasty for treatment of vertebral compression fractures: a meta-analysis of the literature. Spine J (2007) 1.93
Paraplegia as a complication of percutaneous vertebroplasty with polymethylmethacrylate: a case report. Spine (Phila Pa 1976) (2002) 1.90
Balloon kyphoplasty for symptomatic vertebral body compression fractures results in rapid, significant, and sustained improvements in back pain, function, and quality of life for elderly patients. Spine (Phila Pa 1976) (2006) 1.83
Percutaneous vertebroplasty: long-term clinical and radiological outcome. Neuroradiology (2002) 1.78
Vertebroplasty, first 1000 levels of a single center: evaluation of the outcomes and complications. AJNR Am J Neuroradiol (2007) 1.71
Balloon kyphoplasty: one-year outcomes in vertebral body height restoration, chronic pain, and activity levels. J Neurosurg (2003) 1.70
Percutaneous vertebroplasty: new treatment for vertebral compression fractures. Am Fam Physician (2002) 1.65
Cement leakage during vertebroplasty: an underestimated problem? Eur Spine J (2005) 1.64
Balloon kyphoplasty for the treatment of pathological vertebral compressive fractures. Eur Spine J (2004) 1.61
Percutaneous vertebroplasty for osteoporotic compression fractures: quantitative prospective evaluation of long-term outcomes. J Vasc Interv Radiol (2002) 1.61
Percutaneous vertebroplasty for severe osteoporotic vertebral body compression fractures. Radiology (2002) 1.59
Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group. Osteoporos Int (1999) 1.59
Painful osteoporotic vertebral fracture. Pathogenesis, evaluation, and roles of vertebroplasty and kyphoplasty in its management. J Bone Joint Surg Am (2003) 1.59
Early radiographic and clinical results of balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Spine (Phila Pa 1976) (2003) 1.59
Prospective evaluation of pain relief in 100 patients undergoing percutaneous vertebroplasty: results and follow-up. J Vasc Interv Radiol (2002) 1.59
Cementing the evidence: time for a randomized trial of vertebroplasty. AJNR Am J Neuroradiol (2000) 1.55
Pulmonary embolism caused by acrylic cement: a rare complication of percutaneous vertebroplasty. AJNR Am J Neuroradiol (1999) 1.55
Percutaneous vertebroplasty. Radiology (2003) 1.53
Minimally invasive treatments of osteoporotic vertebral compression fractures. Spine (Phila Pa 1976) (2003) 1.51
Vertebral compression fractures in the elderly. Am Fam Physician (2004) 1.50
Impact of postural deformities and spinal mobility on quality of life in postmenopausal osteoporosis. Osteoporos Int (2003) 1.50
An ex vivo biomechanical evaluation of an inflatable bone tamp used in the treatment of compression fracture. Spine (Phila Pa 1976) (2001) 1.47
The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women. BMC Musculoskelet Disord (2002) 1.47
Bone density: BMC, BMD, or corrected BMD? Bone (1995) 1.47
Primary and secondary osteoporosis' incidence of subsequent vertebral compression fractures after kyphoplasty. Spine (Phila Pa 1976) (2004) 1.43
Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma. J Clin Oncol (2002) 1.42
Biomechanical efficacy of unipedicular versus bipedicular vertebroplasty for the management of osteoporotic compression fractures. Spine (Phila Pa 1976) (1999) 1.42
Unilateral transpedicular percutaneous vertebroplasty: initial experience. Radiology (2002) 1.40
Vertebroplasty: clinical experience and follow-up results. Bone (1999) 1.38
Vertebroplasty and kyphoplasty: filler materials. Spine J (2005) 1.38
Percutaneous vertebroplasty for osteoporotic compression fracture: multivariate study of predictors of new vertebral body fracture. Cardiovasc Intervent Radiol (2006) 1.36
Comparing pain reduction following kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures. Pain Physician (2007) 1.34
Acute versus chronic vertebral compression fractures treated with kyphoplasty: early results. Spine J (2004) 1.28
Root and spinal cord compression from methylmethacrylate vertebroplasty. Spine (Phila Pa 1976) (2001) 1.23
Percutaneous vertebroplasty: indications, contraindications, and technique. Br J Radiol (2003) 1.21
Kyphoplasty for vertebral compression fractures: 1-year clinical outcomes from a prospective study. J Neurosurg (2003) 1.18
A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int (1999) 1.18
The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. J Vasc Interv Radiol (2006) 1.17
Preliminary outcomes and efficacy of the first 360 consecutive kyphoplasties for the treatment of painful osteoporotic vertebral compression fractures. Spine J (2005) 1.17
Comparative study of balloon kyphoplasty with unilateral versus bilateral approach in osteoporotic vertebral compression fractures. Int Orthop (2007) 1.15
Risk factors of developing new symptomatic vertebral compression fractures after percutaneous vertebroplasty in osteoporotic patients. Eur Spine J (2006) 1.14
Serious pyogenic spondylitis following vertebroplasty--a case report. Spine (Phila Pa 1976) (2004) 1.14
Combined extraforaminal and intradiscal cement leakage following percutaneous vertebroplasty. Spine (Phila Pa 1976) (2007) 1.10
Intradural cement leakage: a devastatingly rare complication of vertebroplasty. Spine (Phila Pa 1976) (2006) 1.08
An evidence-based evaluation of percutaneous vertebroplasty. Manag Care (2000) 1.08
Infected vertebroplasty due to uncommon bacteria solved surgically: a rare and threatening life complication of a common procedure: report of a case and a review of the literature. Spine (Phila Pa 1976) (2006) 1.06
Kyphoplasty: report of eighty-two thoracolumbar osteoporotic vertebral fractures. J Orthop Trauma (2004) 1.05
New vertebral osteoporotic compression fractures after percutaneous vertebroplasty: retrospective analysis of risk factors. J Vasc Interv Radiol (2008) 1.05
Quality assurance guidelines for percutaneous vertebroplasty. Cardiovasc Intervent Radiol (2006) 1.05
Cement leakage in percutaneous vertebroplasty: effect of preinjection gelfoam embolization. Spine (Phila Pa 1976) (2006) 1.03
Risk factors for perimenopausal fractures: a prospective study. Osteoporos Int (2000) 1.03
Vertebroplasty: experimental characterization of polymethylmethacrylate bone cement spreading as a function of viscosity, bone porosity, and flow rate. Spine (Phila Pa 1976) (2008) 0.99
Pseudarthrosis in primary fusions for adult idiopathic scoliosis: incidence, risk factors, and outcome analysis. Spine (Phila Pa 1976) (2005) 0.98
Distribution of anterior cortical shear strain after a thoracic wedge compression fracture. Spine J (2004) 0.97
Functional outcomes of kyphoplasty for the treatment of osteoporotic and osteolytic vertebral compression fractures. Osteoporos Int (2006) 0.97
Treatment of painful osteoporotic or traumatic vertebral compression fractures by percutaneous vertebral augmentation procedures: a nonrandomized comparison between vertebroplasty and kyphoplasty. Clin J Pain (2007) 0.97
Osteoporotic compression fractures: outcomes after single- versus multiple-level percutaneous vertebroplasty. Radiology (2006) 0.96
Repeat vertebroplasty for unrelieved pain at previously treated vertebral levels with osteoporotic vertebral compression fractures. Spine (Phila Pa 1976) (2008) 0.96
Balloon kyphoplasty for vertebra plana with or without osteonecrosis. J Orthop Surg (Hong Kong) (2008) 0.95
Images in cardiovascular medicine. Pulmonary embolization of acrylic cement during vertebroplasty. Circulation (2006) 0.95
Vertebroplasty and kyphoplasty. Anesthesiol Clin (2007) 0.94
Percutaneous Vertebroplasty. Semin Musculoskelet Radiol (1997) 0.94
Kyphoplasty and vertebroplasty produce the same degree of height restoration. AJNR Am J Neuroradiol (2009) 0.93
Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med (2002) 5.83
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab (2012) 2.87
The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med (2006) 2.74
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res (2015) 2.74
Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res (2008) 2.66
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA (2008) 2.52
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab (2014) 2.38
Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res (2012) 2.34
Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res (2011) 2.30
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA (2004) 2.20
Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab (2014) 1.98
Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med (2006) 1.68
Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study. Arch Dermatol (2009) 1.67
Assessment of gene-by-sex interaction effect on bone mineral density. J Bone Miner Res (2012) 1.58
Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement. J Rheumatol (2005) 1.46
The occurrence of acute myocardial infarction in Italy: a five-year analysis of hospital discharge records. Aging Clin Exp Res (2010) 1.44
The role of estrogens in melanoma and skin cancer. Carcinogenesis (2009) 1.38
Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res (2002) 1.29
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. J Clin Endocrinol Metab (2004) 1.25
Multiple endocrine neoplasia type 2. Orphanet J Rare Dis (2006) 1.23
Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol (2002) 1.21
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet (2011) 1.20
Calcium sensing receptor signalling in physiology and cancer. Biochim Biophys Acta (2012) 1.19
The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study. Arthritis Res Ther (2010) 1.17
Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1? Ann Surg (2007) 1.10
Epidemiology of fragility fractures in Italy. Clin Cases Miner Bone Metab (2011) 1.10
Treatment of desmoids and mesenteric fibromatosis in familial adenomatous polyposis with raloxifene. Tumori (2003) 1.08
Multiple endocrine neoplasia type 1. Orphanet J Rare Dis (2006) 1.08
Updated incidence rates of fragility fractures in Italy: extension study 2002-2008. Clin Cases Miner Bone Metab (2011) 1.08
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone (2007) 1.07
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol (2010) 1.04
Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors. Genet Med (2009) 1.03
Somatostatinoma: clinico-pathological features of three cases and literature reviewed. J Gastroenterol Hepatol (2007) 1.02
Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. Hum Mol Genet (2014) 1.02
Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005. J Exp Clin Cancer Res (2009) 1.02
Total knee arthroplasty in patients with hypersensitivity to metals. Int Orthop (2014) 1.00
Muscle-bone interactions: basic and clinical aspects. Endocrine (2013) 1.00
Determinants of bone turnover markers in healthy premenopausal women. Calcif Tissue Int (2008) 0.99
Cystic bone angiomatosis: a case report treated with aminobisphosphonates and review of the literature. Calcif Tissue Int (2013) 0.97
ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr Relat Cancer (2005) 0.97
A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis (2013) 0.97
Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg (2006) 0.96
Myostatin polymorphisms and age-related sarcopenia in the Italian population. J Am Geriatr Soc (2002) 0.93
The TARGET project in Tuscany: the first disease management model of a regional project for the prevention of hip re-fractures in the elderly. Clin Cases Miner Bone Metab (2010) 0.93
Polyostotic form of fibrous dysplasia in a 13 years old Colombian girl showing clinical and biochemical response to neridronate intravenous therapy. Clin Cases Miner Bone Metab (2009) 0.92
In vitro blockade of receptor activator of nuclear factor-kappaB ligand prevents osteoclastogenesis induced by neuroblastoma cells. Int J Cancer (2004) 0.91
Bone vascularization in normal and disease conditions. Front Endocrinol (Lausanne) (2013) 0.91
MicroRNA Role in Thyroid Cancer Development. J Thyroid Res (2011) 0.91
Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility. Ther Clin Risk Manag (2012) 0.90
Selective oestrogen receptor modulators in desmoid tumours. Expert Opin Investig Drugs (2004) 0.90
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease. J Bone Miner Res (2013) 0.89
The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the "Knudson's second hit". PLoS One (2012) 0.89
Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men. J Clin Endocrinol Metab (2004) 0.89
In vitro differentiation of human mesenchymal stem cells on Ti6Al4V surfaces. Biomaterials (2007) 0.88
Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy? Menopause (2006) 0.88
Multiple endocrine neoplasms. Best Pract Res Clin Rheumatol (2008) 0.88
The burden of breast cancer in Italy: mastectomies and quadrantectomies performed between 2001 and 2008 based on nationwide hospital discharge records. J Exp Clin Cancer Res (2012) 0.88
A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet. Nat Clin Pract Endocrinol Metab (2008) 0.88
Methodological models for in vitro amplification and maintenance of human articular chondrocytes from elderly patients. Biogerontology (2007) 0.88
Inhibition of angiogenesis via FGF-2 blockage in primitive and bone metastatic renal cell carcinoma. Anticancer Res (2007) 0.87
Thyroid cancer: current molecular perspectives. J Oncol (2010) 0.87
Segregation of a M404V mutation of the p62/sequestosome 1 (p62/SQSTM1) gene with polyostotic Paget's disease of bone in an Italian family. Arthritis Res Ther (2005) 0.87
Can fibroblast growth factor (FGF)-23 circulating levels suggest coronary artery abnormalities in children with Kawasaki disease? Clin Exp Rheumatol (2013) 0.86
Incidence and costs of hip fractures vs strokes and acute myocardial infarction in Italy: comparative analysis based on national hospitalization records. Clin Interv Aging (2012) 0.86
Pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: review of literature. Endocr Pract (2011) 0.86
Denosumab significantly increases DXA BMD at both trabecular and cortical sites: results from the FREEDOM study. J Clin Densitom (2012) 0.85
Skin lesions in hereditary endocrine tumor syndromes. Endocr Pract (2011) 0.85
Novel 1113delC menin gene mutation in a Polish family with multiple endocrine neoplasia type 1 syndrome. Eur J Intern Med (2006) 0.85
Pharmacological treatment of hip fractured patients in Italy: a simulation based on Tuscany regional database for the TARGET project. Clin Cases Miner Bone Metab (2010) 0.85
Antifracture drugs consumption in Tuscany Region before the Target Project: a valuable model for the analysis of administrative database. Clin Cases Miner Bone Metab (2012) 0.85
Management of osteoporosis with PTH: treatment and prescription patterns in Europe. Curr Med Res Opin (2009) 0.85
Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury? J Rheumatol (2004) 0.85
Decreased transcriptional activity of calcium-sensing receptor gene promoter 1 is associated with calcium nephrolithiasis. J Clin Endocrinol Metab (2013) 0.84
The effectiveness and safety of vertebroplasty for osteoporotic vertebral compression fractures. A double blind, prospective, randomized, controlled study. Clin Cases Miner Bone Metab (2010) 0.84
Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis. Drugs Aging (2015) 0.84
Large gradient high magnetic field affects FLG29.1 cells differentiation to form osteoclast-like cells. Int J Radiat Biol (2012) 0.84
Low adherence of a clinically healthy Italian population to nutritional recommendations for primary prevention of chronic diseases. Nutr Metab Cardiovasc Dis (2006) 0.84
Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture. J Bone Miner Res (2004) 0.84
Expression of cyclooxygenase-2 in osteosarcoma of bone. Appl Immunohistochem Mol Morphol (2007) 0.84
Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis. Curr Med Res Opin (2008) 0.83
Osteodifferentiation of human preadipocytes induced by strontium released from hydrogels. Int J Biomater (2012) 0.83
Growth response of colon cancer cell lines to selective estrogen receptor modulators. Anticancer Res (2003) 0.83
The regulatory network menin-microRNA 26a as a possible target for RNA-based therapy of bone diseases. Nucleic Acid Ther (2012) 0.83
Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis. Fertil Steril (2006) 0.83
Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas). Neuroendocrinology (2007) 0.83
Age-specific effects of estrogen receptors' polymorphisms on the bone traits in healthy fertile women: the BONTURNO study. Reprod Biol Endocrinol (2009) 0.83
Genetic determinants of osteoporosis: common bases to cardiovascular diseases? Int J Hypertens (2010) 0.83
Inhibition of angiogenic activity of renal carcinoma by an antisense oligonucleotide targeting fibroblast growth factor-2. Anticancer Res (2005) 0.83
Gaucher disease and bone manifestations. Calcif Tissue Int (2014) 0.83
Genetic epidemiology of Paget's disease of bone in italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of bone. Calcif Tissue Int (2008) 0.82
A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. Eur J Endocrinol (2012) 0.82
Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders. Expert Opin Pharmacother (2002) 0.82
Phytoestrogens: food or drug? Clin Cases Miner Bone Metab (2007) 0.82
Compliance to antifracture treatments in Tuscany: a regional survey based on institutional pharmaceutical dataset. Clin Cases Miner Bone Metab (2011) 0.82
Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats. Mediators Inflamm (2013) 0.82
Surgical management of insulinomas in multiple endocrine neoplasia type 1. Pancreas (2012) 0.81
Pharmacogenetics of bone treatments: the VDR and ERalpha gene story. Pharmacogenomics (2008) 0.81
Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw. Front Biosci (Elite Ed) (2011) 0.81